TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
35 hedge funds and large institutions have $24M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
11
Reduced
7
Closed
5
Calls
$748K
Puts
$80K
Net Calls
+$668K
Net Calls Change
+$35K
Top Buyers
1 |
LA
1
Linden Advisors
New York
|
$1.2M |
2 |
IC
2
Ikarian Capital
Dallas,
Texas
|
$7.48M |
3 |
OM
3
Opaleye Management
Boston,
Massachusetts
|
$8.3M |
4 |
4
Bank of New York Mellon
New York
|
$374K |
5 |
5
Citadel Advisors
Miami,
Florida
|
$131K |